Previous studies have uncovered that some cytokines, such as interleukin 6, 15, and 18(IL-6, IL-15, and IL-18), in peripheral blood are associated with the treatment outcomes of ICIs in NSCLC [9–11]. The gene discussed is IL6; the disease is non-small cell lung carcinoma.